On the other hand, estrogen receptor (ER), progesterone receptor (PR), and C-erbB-2 (i.e. human epidermal growth factor receptor 2 [HER 2]) expression are the most important prognostic factors for management of breast cancer, particularly in metastatic disease settings and adjuvant treatment. Here, ESR1 is linked to metastatic neoplasm.